Doctor profile · Federal record
Dr. Matthew Arkebauer, D.O.
Rheumatology Physician (CMS: Rheumatology) · Vineland, NJ
- NPI 1801148697
- Accepts Medicare
- MIPS 0.0 / 100 · 2023
- 15 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2848 S Delsea Dr, Ste 2C
Vineland, NJ 083607042
(856) 794-9090
fax (856) 794-3058 - Mailing address
-
2848 S Delsea Dr Ste 2C
Vineland, NJ 083607042
Credentials & registration
- NPI registered
- October 2012 — 14 yrs on file
- Profile last updated
- February 8, 2024
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- New Jersey #25MB09849200
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1801148697. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
28,113
Distinct HCPCS
10
Medicare allowed
$632,696
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 11,676 | 38 | $13 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 5,148 | 70 | $32 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 4,112 | 282 | $1 | |
J0897 |
Injection, denosumab, 1 mg | 2,521 | 34 | $23 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 861 | 424 | $95 | |
20610 |
Aspiration and/or injection of fluid from large joint | 435 | 210 | $85 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 288 | 20 | $0 | |
77080 |
Dxa bone density measurement of hip, pelvis, spine | 274 | 274 | $41 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 194 | 85 | $29 | |
73560 |
X-ray of knee, 1-2 views | 187 | 94 | $38 |
In context: peer comparison
Among 2 peers in Vineland Rheumatology Physician, average services per provider: 2,052. This provider delivers 14× the peer median.Open Payments
Industry payments received
All-time total
$702
Transactions
45
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 20 | $298.65 | |
| Janssen Biotech, INC. | 7 | $110.43 | |
| GlaxoSmithKline, LLC. | 4 | $55.11 | |
| Alexion Pharmaceuticals, INC. | 2 | $37.75 | |
| Amgen INC. | 2 | $33.82 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $32.23 | |
| Radius Health, INC. | 1 | $23.22 | |
| Pfizer INC. | 1 | $16.98 | |
| Aurinia Pharma U.S., INC. | 1 | $16.81 | |
| Fresenius Kabi USA, LLC | 1 | $16.72 | |
| Genzyme Corporation | 1 | $16.53 | |
| Genentech USA, INC. | 1 | $15.37 | |
| Ani Pharmaceuticals, INC. | 1 | $15.24 | |
| Ucb, INC. | 1 | $13.33 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
5,323
Patients
1,213
Total drug cost
$152,508
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 1,528 | 310 | $54,027 |
| Methylprednisolone | Generic | 1,054 | 278 | $28,360 |
| Tramadol Hcl | Generic | 668 | 116 | $8,894 |
| Hydroxychloroquine Sulfate | Generic | 380 | 99 | $19,276 |
| Prednisone | Generic | 301 | 69 | $3,109 |
| Gabapentin | Generic | 269 | 61 | $7,299 |
| Allopurinol | Generic | 239 | 56 | $4,113 |
| Pregabalin | Generic | 171 | 39 | $5,914 |
| Zolpidem Tartrate | Generic | 129 | 29 | $1,375 |
| Duloxetine Hcl | Generic | 126 | 27 | $4,961 |
Hospital affiliations
Frequently asked questions
What is Dr. Matthew Arkebauer's medical specialty?
Dr. Matthew Arkebauer practices Rheumatology Physician in Vineland, NJ.
Where does Dr. Matthew Arkebauer practice?
Dr. Matthew Arkebauer practices at 2848 S Delsea Dr, Vineland, NJ 083607042. Office phone: 8567949090.
What is Dr. Matthew Arkebauer's NPI?
Dr. Matthew Arkebauer's National Provider Identifier (NPI) is 1801148697, issued by NPPES.
Does Dr. Matthew Arkebauer accept Medicare assignment?
Yes. Dr. Matthew Arkebauer accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Matthew Arkebauer commonly perform?
Top Medicare-reported procedures in 2023: Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745); Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS J3301). Source: CMS Medicare Physician & Other Practitioners file.